Renaissance Technologies’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,009,606
| Closed | -$24.1M | – | 3936 |
|
|
2021
Q1 | $24.1M | Sell |
1,009,606
-450,229
| -31% | -$8.37M | 0.03% | 665 |
|
|
2020
Q4 | $21.3M | Sell |
1,459,835
-1,246,765
| -46% | -$16.5M | 0.02% | 721 |
|
|
2020
Q3 | $38.4M | Buy |
2,706,600
+33,100
| +1% | +$506K | 0.04% | 463 |
|
|
2020
Q2 | $39.3M | Buy |
2,673,500
+2,092,200
| +360% | +$21.3M | 0.03% | 504 |
|
|
2020
Q1 | $2.4M | Sell |
581,300
-133,600
| -19% | -$626K | ﹤0.01% | 1965 |
|
|
2019
Q4 | $3.44M | Buy |
714,900
+159,400
| +29% | +$879K | ﹤0.01% | 2067 |
|
|
2019
Q3 | $3.37M | Buy |
555,500
+216,400
| +64% | +$1.35M | ﹤0.01% | 2016 |
|
|
2019
Q2 | $2.2M | Buy |
339,100
+206,965
| +157% | +$1.46M | ﹤0.01% | 2270 |
|
|
2019
Q1 | $937K | Buy |
+132,135
| New | +$870K | ﹤0.01% | 2700 |
|
|
2016
Q4 | – | Sell |
-109,000
| Closed | -$1.29M | – | 3562 |
|
|
2016
Q3 | $1.29M | Buy |
+109,000
| New | +$1.05M | ﹤0.01% | 2436 |
|
|
2016
Q2 | – | Sell |
-71,300
| Closed | -$376K | – | 3584 |
|
|
2016
Q1 | $376K | Buy |
+71,300
| New | +$397K | ﹤0.01% | 2923 |
|
Renaissance Technologies's GNMK Position: Q2 2021 in Review
Renaissance Technologies sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 1,009,606 shares — an estimated $24.1M sold.
Renaissance Technologies first reported a position in GNMK in Q1 2016 and held it in 11 quarters. The position peaked at $39.3M in Q2 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Renaissance Technologies reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Renaissance Technologies sold 1,009,606 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $24.1M.
- Renaissance Technologies first reported a position in GenMark Diagnostics, Inc in Q1 2016 and held it in 11 quarters.
- Renaissance Technologies's GenMark Diagnostics, Inc position peaked at $39.3M in Q2 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.